Phaeanthus vietnamensis

Phaeanthus vietnamensis · Accepted scientific name

Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆

Phaeanthus vietnamensis is a notable botanical species currently being investigated for its diverse pharmacological potential. Recent scientific studies have focused specifically on the leaf extracts, referred to as PVE, to evaluate their therapeutic properties. This particular preparation has demonstrated significant efficacy in addressing physiological challenges such as oxidative stress. Furthermore, research suggests that the plant may offer protective benefits for managing conditions like asthma. Understanding these bioactive mechanisms provides a foundation for future medicinal applications of this species.

Quick facts
Synonyms
Not available
Common names
Not available
Family
Annonaceae
Distribution
Africa
Plant Parts
Leaf

Classification

Taxonomy

Phaeanthus vietnamensis is a unique botanical specimen belonging to the kingdom Plantae. This plant is classified under the class Equisetopsida and falls within the order Magnoliales. Within this order, it is further categorized into the family Annonaceae. It serves as a primary representative of its specific genus, Phaeanthus. Understanding these taxonomic relationships helps botanists better appreciate its place in the natural world.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Magnoliales
Family Annonaceae
Genus Phaeanthus

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Phaeanthus vietnamensis is a distinct botanical species primarily recognized for its specific geographic presence within the tropical regions of Asia. Its natural distribution is centered within the Indo-China peninsula, where it thrives in lush, humid environments. More specifically, this plant is a characteristic element of the native flora found throughout Vietnam. Understanding its localized habitat is essential for researchers studying the biodiversity of Southeast Asian ecosystems. Consequently, its limited range makes it a significant subject for regional conservation efforts.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Biological Activities

Compounds

Conditions

Phaeanthus vietnamensis serves as an efficacious agent for treating asthma and managing the complexities of an asthmatic condition. Research indicates that the extract can effectively improve asthma exacerbation by balancing the Th1/Th2 ratio and reducing inflammatory cells. Furthermore, the plant helps treat lower airway inflammation through the activation of antioxidant enzymes like Nrf2 and HO-1. Due to its diverse medicinal properties, it is also utilized in traditional medicine for treating various inflammatory diseases. These therapeutic effects are supported by the plant's ability to inhibit nitric oxide production in stimulated cells.

Preparations

Phaeanthus vietnamensis is prepared as an extract known as PVE to investigate its therapeutic potential. This specific extract was utilized in an experimental study to evaluate its effects on an OVA-induced asthmatic mouse model. Researchers administered various oral doses of PVE, ranging from 50 to 200 mg/kg, to observe its impact on airway inflammation. The results indicated that PVE, particularly at the 200 mg/kg dose, effectively ameliorates asthma exacerbation by modulating key signaling pathways. Consequently, the preparation of Phaeanthus vietnamensis as PVE serves as a crucial method for exploring its medicinal properties in treating respiratory diseases.

Parts used

Phaeanthus vietnamensis is a well-known medicinal plant traditionally utilized for the treatment of various inflammatory diseases. Recent scientific investigations have focused on isolating specific chemical components from the leaves of this species. Through various chromatographic methods, researchers successfully identified several new and known compounds within the leaf extracts. These isolated substances were then evaluated for their ability to inhibit nitric oxide production in LPS-stimulated BV2 cells. The study ultimately highlighted specific compounds that demonstrate significant potency in managing inflammatory responses.